418 related articles for article (PubMed ID: 29393911)
1. The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.
Escalona RM; Chan E; Kannourakis G; Findlay JK; Ahmed N
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393911
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
3. Introduction: MMPs, ADAMs/ADAMTSs research products to achieve big dream.
Okazaki I; Nabeshima K
Anticancer Agents Med Chem; 2012 Sep; 12(7):688-706. PubMed ID: 22292751
[TBL] [Abstract][Full Text] [Related]
4. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
Hida Y; Hamada J
Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
6. Comparative gene expression profiling of ADAMs, MMPs, TIMPs, EMMPRIN, EGF-R and VEGFA in low grade meningioma.
Rooprai HK; Martin AJ; King A; Appadu UD; Jones H; Selway RP; Gullan RW; Pilkington GJ
Int J Oncol; 2016 Dec; 49(6):2309-2318. PubMed ID: 27779709
[TBL] [Abstract][Full Text] [Related]
7. Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer.
Zhang Y; Chen Q
Braz J Med Biol Res; 2017 May; 50(6):e6104. PubMed ID: 28538838
[TBL] [Abstract][Full Text] [Related]
8. Tissue inhibitors of metalloproteinases.
Murphy G
Genome Biol; 2011 Nov; 12(11):233. PubMed ID: 22078297
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma.
Ripley D; Tunuguntla R; Susi L; Chegini N
Int J Gynecol Cancer; 2006; 16(5):1794-800. PubMed ID: 17009974
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
Cui Y; Yu J; Urban JP; Young DA
Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of matrix metalloproteinases during stimulated ovarian recrudescence in Siberian hamsters (Phodopus sungorus).
Salverson TJ; McMichael GE; Sury JJ; Shahed A; Young KA
Gen Comp Endocrinol; 2008 Feb; 155(3):749-61. PubMed ID: 17980368
[TBL] [Abstract][Full Text] [Related]
13. Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo.
Vassilev V; Pretto CM; Cornet PB; Delvaux D; Eeckhout Y; Courtoy PJ; Marbaix E; Henriet P
J Clin Endocrinol Metab; 2005 Oct; 90(10):5848-57. PubMed ID: 16046583
[TBL] [Abstract][Full Text] [Related]
14. MMPs in ovarian cancer as therapeutic targets.
Karam A; Dorigo O
Anticancer Agents Med Chem; 2012 Sep; 12(7):764-72. PubMed ID: 22292752
[TBL] [Abstract][Full Text] [Related]
15. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration.
Vo NV; Hartman RA; Yurube T; Jacobs LJ; Sowa GA; Kang JD
Spine J; 2013 Mar; 13(3):331-41. PubMed ID: 23369495
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
18. The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio.
Huxley-Jones J; Clarke TK; Beck C; Toubaris G; Robertson DL; Boot-Handford RP
BMC Evol Biol; 2007 Apr; 7():63. PubMed ID: 17439641
[TBL] [Abstract][Full Text] [Related]
19. Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families.
He XX; Shi LL; Qiu MJ; Li QT; Wang MM; Xiong ZF; Yang SL
Biochem Biophys Res Commun; 2018 Oct; 504(4):878-884. PubMed ID: 30219235
[TBL] [Abstract][Full Text] [Related]
20. Alternations in the expression of selected matrix metalloproteinases (MMP-2, -9, -10, and -13) and their tissue inhibitors (TIMP-2 and -3) and MMP-2 and -9 activity in the chicken ovary during pause in laying induced by fasting.
Wolak D; Hrabia A
Theriogenology; 2021 Feb; 161():176-186. PubMed ID: 33333443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
